We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
-1.22%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$526M
AUM Growth
-$4.9M
Cap. Flow
+$3.41M
Cap. Flow %
0.65%
Top 10 Hldgs %
33.37%
Holding
151
New
6
Increased
38
Reduced
84
Closed
10

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$2.88M
2
MDU icon
MDU Resources
MDU
+$2.59M
3
IBM icon
IBM
IBM
+$2M
4
CMC icon
Commercial Metals
CMC
+$1.84M
5
HPQ icon
HP
HPQ
+$1.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.08%
2 Industrials 21.35%
3 Technology 17.46%
4 Energy 7.75%
5 Utilities 7.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
26
Microsoft
MSFT
$3.35T
$5.52M 1.05%
135,700
-2,305
-2% -$100K
TT icon
27
Trane Technologies
TT
$97.3B
$5.44M 1.03%
79,870
-975
-1% -$64.4K
MDU icon
28
MDU Resources
MDU
$4.17B
$5.42M 1.03%
667,491
+305,487
+84% +$2.59M
EWS icon
29
iShares MSCI Singapore ETF
EWS
$1.05B
$5.4M 1.03%
210,838
+4,650
+2% +$119K
DRC
30
DELISTED
DRESSER-RAND GROUP INC
DRC
$5.29M 1%
65,774
-1,700
-3% -$138K
AMGN icon
31
Amgen
AMGN
$209B
$5.24M 1%
32,793
-1,150
-3% -$181K
OGE icon
32
OGE Energy
OGE
$9.76B
$4.93M 0.94%
155,905
+24,050
+18% +$806K
POR icon
33
Portland General Electric
POR
$5.8B
$4.86M 0.92%
131,085
-5,200
-4% -$196K
TMO icon
34
Thermo Fisher Scientific
TMO
$214B
$4.58M 0.87%
34,133
-1,750
-5% -$226K
CYT
35
DELISTED
CYTEC INDS INC
CYT
$4.49M 0.85%
83,100
-2,600
-3% -$130K
EEMV icon
36
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.45B
$4.43M 0.84%
75,100
+3,900
+5% +$226K
ALTR
37
DELISTED
Altera Corp
ALTR
$4.41M 0.84%
102,650
+13,050
+15% +$467K
EXC icon
38
Exelon
EXC
$46.6B
$4.35M 0.83%
181,629
-8,875
-5% -$220K
MMM icon
39
3M
MMM
$90.8B
$4.34M 0.82%
31,456
-1,884
-6% -$260K
AMAT icon
40
Applied Materials
AMAT
$398B
$4.06M 0.77%
179,810
-2,400
-1% -$57.5K
LLY icon
41
Eli Lilly
LLY
$1.03T
$3.96M 0.75%
54,438
-12,150
-18% -$865K
TMP icon
42
Tompkins Financial
TMP
$1.42B
$3.83M 0.73%
71,135
-1,410
-2% -$74.2K
ITRI icon
43
Itron
ITRI
$4.33B
$3.74M 0.71%
102,550
+9,500
+10% +$354K
IXYS
44
DELISTED
IXYS Corp
IXYS
$3.72M 0.71%
301,615
+4,600
+2% +$55K
DIS icon
45
Walt Disney
DIS
$167B
$3.69M 0.7%
35,152
-1,400
-4% -$141K
FLS icon
46
Flowserve
FLS
$9.63B
$3.66M 0.7%
64,825
+17,420
+37% +$1.01M
EWA icon
47
iShares MSCI Australia ETF
EWA
$1.41B
$3.56M 0.68%
155,715
+48,590
+45% +$1.11M
HOLX
48
DELISTED
Hologic
HOLX
$3.24M 0.62%
98,160
-1,890
-2% -$58K
EEM icon
49
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$3.19M 0.61%
79,410
-1,340
-2% -$53.3K
SIAL
50
DELISTED
SIGMA - ALDRICH CORP
SIAL
$3.17M 0.6%
22,933
-1,050
-4% -$145K

Similar funds

John G. Ullman & Associates's Q1 2015 Portfolio in Review

As of Q1 2015, John G. Ullman & Associates held 151 positions worth $526M, down 0.92% from $531M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q1 2015 filing shows 6 new, 38 increased, 84 reduced and 10 closed positions. Its largest new stake was HP: 103,274 shares worth $1.46M. The largest sale was Medtronic, an estimated $5.19M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q1 2015 buy was HP: 103,274 shares worth $1.46M.
  • John G. Ullman & Associates added most to ExxonMobil in Q1 2015, an estimated $2.88M increase.
  • John G. Ullman & Associates's biggest Q1 2015 reduction was Bristol-Myers Squibb, cutting an estimated $3.59M.
  • John G. Ullman & Associates fully exited Medtronic in Q1 2015, selling an estimated $5.19M.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $526M portfolio in Q1 2015.
  • John G. Ullman & Associates opened 6 new positions and closed 10 in Q1 2015.
  • John G. Ullman & Associates's portfolio value fell 0.92% quarter-over-quarter to $526M.

Based on John G. Ullman & Associates's 13F filing for Q1 2015, filed 13 May 2015.